#Germany #Cologne #Dental AI #IDS 2025 #DeepCare

DeepCare's Breakthrough at IDS 2025

From March 25 to 29, 2025, in Cologne, Germany, DeepCare, a frontrunner in dental AI technology, made headlines by unveiling its transformative Multimodal Dental AI Agent and advanced CBCT AI functionalities at the prestigious International Dental Show (IDS 2025). This event is recognized as the largest and most significant dental exhibition worldwide, attracting industry leaders and experts keen to explore the latest innovations in dental technology. This was DeepCare's second showcase at IDS, following a successful entry in 2023.

The Multimodal Dental AI Agent marks a significant leap in how clinical dental practices can leverage technology. By integrating AI-assisted diagnosis, treatment planning, and real-time patient consultations, this agent processes six types of imaging modalities including panoramic X-rays, CBCT scans, and intraoral photographs. This comprehensive analysis allows for the detection of almost 40 different dental conditions, significantly aiding dentists in making quicker and more informed treatment decisions.

Unlike conventional dental AI models, DeepCare's innovation goes beyond basic data usage. Its AI Agent provides context-based reasoning for clinical cases, employing historical patient data, real-time clinical guidelines, and specific patient factors such as age, growth stage, and even financial considerations. For instance, when treating pediatric patients, the AI takes developmental factors into account, rather than outright recommending implants for missing primary teeth, which can often lead to unnecessary complications.

On the patient interaction front, the DeepCare AI Agent offers an intuitive conversational interface. Patients can engage through text, voice, or image inputs to receive personalized recommendations for dental specialists, guidance on treatment options, and even oral self-check tools tailored to their individual health advice. This level of interaction is poised to enhance the patient experience significantly, allowing for more personalized and effective dental care.

Additionally, the updated CBCT AI capabilities bring advanced functionalities to the table. The technology now supports cranial segmentation and reconstruction, which provides clear visibility of complex structures such as the mandibular fossa and the sphenoid bone—critical areas for accurate diagnosis and treatment planning. Moreover, it boasts automated 3D segmentation features for periapical lesions, including abnormalities in the maxillary sinus. This enables dentists to evaluate lesion size, shape, and volume with an unprecedented level of accuracy. A novel color rendering system enhances the contrast of CBCT scans, making them easier to interpret and follow.

Dr. Eric Ding, Founder and CEO of DeepCare, stated, "After years of dedicated development, we are proud to serve tens of thousands of clinics and millions of patients across more than 60 countries, including regions from North America to Europe and the Middle East.” He added, “With our innovative Multimodal Dental AI Agent and upgraded CBCT capabilities, we aim to empower dentists with advanced decision-support tools, improve personalized patient care, and optimize operational efficiency. At IDS 2025, we are excited to explore collaborative opportunities with global experts to shape the future of dental AI.”

As DeepCare continues to pave the way in dental artificial intelligence, its efforts underscore a commitment to enhancing patient care and transforming dental practices worldwide. More information about DeepCare's offerings can be found at deepcare.com.